Business Description
Odonate Therapeutics Inc
NAICS : 325414
SIC : 2836
3 East 28th Street, 10th Floor, New York, NY, USA, 10016
Compare
Compare
Traded in other countries / regions
4OD.Germany
•
ODTC.USA
Description
Odonate Therapeutics Inc is a Shell company.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 19.6 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 0 | |||||
| Beneish M-Score | 0 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -18.7 | |||||
| 3-Year EPS without NRI Growth Rate | -18.5 | |||||
| 3-Year FCF Growth Rate | -23.6 | |||||
| 3-Year Book Growth Rate | -21.5 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.11 | |||||
| 9-Day RSI | 48.71 | |||||
| 14-Day RSI | 46.13 | |||||
| 6-1 Month Momentum % | 20.45 | |||||
| 12-1 Month Momentum % | -52.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.29 | |||||
| Quick Ratio | 3.29 | |||||
| Cash Ratio | 3.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12.8 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -90.64 | |||||
| ROA % | -69.52 | |||||
| ROIC % | -859.35 | |||||
| ROC (Joel Greenblatt) % | -1530.32 | |||||
| ROCE % | -78.49 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.73 | |||||
| Price-to-Tangible-Book | 0.73 | |||||
| EV-to-EBIT | 0.42 | |||||
| EV-to-EBITDA | 0.42 | |||||
| EV-to-FCF | 0.4 | |||||
| Price-to-Net-Current-Asset-Value | 0.8 | |||||
| Price-to-Net-Cash | 0.85 | |||||
| Earnings Yield (Greenblatt) % | 238.25 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with OTCPK:ODTC
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0 | ||
| EPS (TTM) ($) | -2.69 | ||
| Beta | -0.29 | ||
| Volatility % | 63.47 | ||
| 14-Day RSI | 46.13 | ||
| 14-Day ATR ($) | 0.069089 | ||
| 20-Day SMA ($) | 1.3555 | ||
| 12-1 Month Momentum % | -52.96 | ||
| 52-Week Range ($) | 0.8077 - 3.54 | ||
| Shares Outstanding (Mil) | 38.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Odonate Therapeutics Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||